For the Inventor, By the Inventor

Enter assignee name

Horsholm, Denmark

Roche Innovation Center Copenhagen A/s

USPTO Granted Patents = 46

CIPO Patents = 39

EPO Patents = 40

Forward Citations = 120

Loading Chart...

Loading Chart...

155 inventors (with patents filed for the assignee):

Jacob Ravn (13 out of 17 patents)

Henrik Frydenlund Hansen (13 out of 32 patents)

Troels Koch (9 out of 25 patents)

4. Christoph Rosenbohm (9 out of 17 patents)

5. Maj Hedtjärn (8 out of 14 patents)

6. Marie Wickstrom Lindholm (8 out of 8 patents)

7. Niels Fisker Nielsen (8 out of 13 patents)

8. Dennis Jul Hansen (8 out of 9 patents)

9. Andreas Petri (8 out of 12 patents)

10. Erik Daa Funder (7 out of 9 patents)

11. Nanna Albæk (7 out of 7 patents)

12. Majken Westergaard (7 out of 17 patents)

13. Charlotte Albaek Thrue (7 out of 19 patents)

14. Henrik Orum (6 out of 14 patents)

15. Peter Hagedorn (5 out of 17 patents)

46 patents: Sort by Forward Citations

1. 12421552 - MicroRNA-134 biomarker (2025-09-23),

2. 12421516 - Antisense oligomers targeting PCSK9 (2025-09-23),

3. 12421268 - Process for preparing nucleotide P(V) monomers (2025-09-23),

4. 12344625 - Process for preparing rhenium chelated MAG3 oligonucleotides (2025-07-01),

5. 12241065 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2025-03-04),

6. 12180478 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2024-12-31),

7. 11814407 - Multiple coupling and oxidation method (2023-11-14),

8. 11739332 - Antisense oligomers targeting PCSK9 (2023-08-29),

9. 11667660 - Pyridinium salts as activators in the synthesis of stereodefined oligonucleotides (2023-06-06),

10. 11597926 - Thiophosphoramidites (2023-03-07),

11. 11591594 - LNA-G process (2023-02-28),

12. 11591362 - Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides (2023-02-28),

13. 11555050 - Oligonucleotide conjugation process (2023-01-17),

14. 11542294 - Rapid unylinker cleavage (2023-01-03),

15. 11447775 - Antisense oligonucleotides targeting alpha-synuclein and uses thereof (2022-09-20),

Roche Innovation Center Copenhagen A/S is a leading pharmaceutical company committed to advancing medical science and improving patient outcomes. With a focus on research and development, we strive to develop innovative solutions for a wide range of diseases. Through collaboration and cutting-edge technologies, we aim to make a meaningful difference in the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

46 Patents

#2 in Horsholm

#68 in Denmark

#14,652 in the World

Horsholm, Denmark

Roche Innovation Center Copenhagen A/s

Forward Citations = 120

155 inventors:

Jacob Ravn (13 out of 17 patents)

Henrik Frydenlund Hansen (13 out of 32 patents)

Troels Koch (9 out of 25 patents)

4. Christoph Rosenbohm (9 out of 17 patents)

5. Maj Hedtjärn (8 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…